Clinical Trial Update: Tempus Priority Study: A Pan-tumor Observational Study

View source ↗

Summary

Tempus AI's Pan-tumor Priority Study is an observational cancer study that is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Brain Cancer
• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Ovarian Cancer
• Pancreatic Cancer
• Prostate Cancer

Snippet

Sponsor: Tempus AI | Conditions: Breast Cancer, Prostate Cancer | Status: ACTIVE_NOT_RECRUITING